Sound waves aimed at the brain could quiet tics without surgery

NCT ID NCT07699783

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This phase 1 trial tests whether low-energy focused ultrasound can safely and temporarily reduce tics in people with Tourette syndrome. Twenty participants aged 16 and older receive ultrasound to deep brain regions or the motor cortex, or a sham treatment, across four sessions. The goal is to see if this non-invasive approach can modulate the brain circuits involved in tic generation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
focused ultrasound stimulation
What this could lead to
If successful, this could offer a non-invasive, precise way to reduce tics in Tourette syndrome without surgery or medication.
What could go wrong
This is an early phase 1 trial with only 20 participants, so results may not apply broadly. The effects are temporary (up to 60 minutes) and the approach is highly technical, requiring exact targeting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOURETTE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.